22 results
Myelodysplastic Syndrome (MD) - Diagnosis and Management Summary
myelo (marrow) -dys- (abnormal) -plastic (shape) = funny-shaped cells
Diagnosis and Management ... = funny-shaped cells ... only curative treatment ... #treatment #hematology ... #oncology
An Algorithm for the Management of Seizures

The management of active seizures is algorithmic, starting with a
Algorithm for the Management ... and bag-valve mask ... Pharmacologic treatment ... The focus is on ... #Emergency #Neurology
Bell's Palsy - Diagnosis and Management Summary - GrepMed Handbook

Acute Idiopathic Unilateral Facial Nerve (CN7) Palsy
Presentation:
Bell's Palsy - Diagnosis ... and Management ... delayed recovery Management ... Palsy #Diagnosis #Management ... #Treatment #Neurology
Chronic Lymphocytic Leukemia (CLL) - Summary
Overview: 
 • Most common leukemia in adults
 • Disorder of
lymphocytes, smudge cells ... transformation) Treatment ... AIHA, PRCA) • Treatment ... Lymphocytic #Leukemia #oncology ... hemeonc #diagnosis #management
Tumor Lysis Syndrome
An acute, life-threatening condition that appears within 7 days of starting cytotoxic therapies in
spontaneously (before any treatments ... malignancies Treatments ... Walid Malki, MD, MS ... Syndrome #TLS #oncology ... #management #UricAcid
Multiple Sclerosis - Summary

Multiple Sclerosis (MS) is an autoimmune-mediated neurodegenerative disease of the central nervous system
Multiple Sclerosis Treatment ... objective evidence of neurologic ... sclerosis #diagnosis #management ... #neurology #treatment ... #MS
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Triggers: ATRA treatment ... Release from blast cells ... Renal Failure Treatment ... APML #diagnosis #management ... #hematology #oncology
Aplastic Anemia - Overview

Who?
• M = F
• 3 peaks:	1) Childhood	2) 15-25 years	3) >60 years

What?
• Aplastic anemia
number of CD34+ cells ... number of CD34+ cells ... aplastic anemia Treatment ... Aplastic #Anemia #oncology ... hematology #diagnosis #management
Myasthenia Gravis Overview

Myasthenia Gravis is an autoimmune disorder of the postsynaptic neuromuscular junction.  Ab to
immunologic assay - MuSK ... Myasthenia Gravis Treatment ... - Symptomatic Treatment ... Gravis #diagnosis #management ... #neurology
Myasthenia Gravis - Summary
 • an autoimmune disease of the postsynaptic neuromuscular junction associated with antibodies
anti—muscle-specific kinase (MuSK ... antibodies - MuSK-positive ... treatment Of ocular ... Gravis #diagnosis #management ... #neurology #treatment